Products for Research Use Only
RegisterLogin

MRE-269

CAT: 0931-T3S2007-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T3S2007-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
475085-57-5
Target
Prostaglandin Receptor
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Purity
0.9957
Bioactivity
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .
Smiles
N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T206867-01Antibacterial agent 269
T206585-01Anticancer agent 269
T26411-01A 269A
T16343-01NRC-2694
T23024MRS 2690
T202459-01LJ-2698
T71332-01NRC-2694 hydrochloride
T71331-01NRC-2694 dihydrochloride
T23025-01MRS 2693 trisodium salt
T24994-01MreB Perturbing Compound A22 hydrochloride

Alternative Products

CatalogName
456637-01MRE-269
HY-79593S1-01MRE-269-d6
HY-79593S2-01MRE-269-d7
HY-79593R-01MRE-269 (Standard)
456641-01MRE-269-d8
456640-01MRE-269-d10
C11380-5mgMRE-269 (ACT-333679)
456639MRE-269 β-D-Glucuronide
HY-79593S3MRE-269-d7 (sodium)
TRC-M750115-25MGMRE-269 beta-D-Glucuronide

Popular Products